Clinical trial Recruiting at 1 site Interventional Ages 20 to 90

Using Clostridium Butyricum Miyairisan to treat symptoms of Parkinson's Disease

Official title: The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

Run by Kaohsiung Medical University Chung-Ho Memorial Hospital · NCT06548256 · Data updated 2026-11-12

This study is testing if a treatment called Clostridium Butyricum Miyairisan can help improve both movement and daily life for people with Parkinson's disease.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages20 Years to 90 Years
SexAll
Enrollment400 (estimated)
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital
Academic / other
Locations1 site (Kaohsiung City)
StatusRecruiting
StartedOctober 31, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 12, 2024
Trial IDNCT06548256 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 20 years old who have been diagnosed with Parkinson's disease.

Probably not a fit

Patients with Parkinson's disease dementia or lactose intolerance may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Clostridium Butyricum Miyairi in alleviating both motor and non-motor symptoms in patients with Parkinson's disease. It is an open-label, single-center, non-randomized trial where participants will receive the treatment and undergo assessments to measure outcomes. The study aims to gather data on how this intervention impacts the quality of life for those affected by Parkinson's disease.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the management of symptoms in Parkinson's disease patients.

How similar studies have gone: While this approach is relatively novel, similar studies exploring gut microbiota and neurological conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female over 20 years old, diagnosed with Parkinson's disease.

Exclusion Criteria:

* People with Parkinson's disease Dementia, or Lactose Intolerance

Where it's running

  • Kaohsiung Medical Univeristy Hospital
    Kaohsiung City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.